Methods For Treating Cancer And The Use Of Biomarkers As A Predictor Of Clinical Sensitivity To Therapies - EP3399980
The patent EP3399980 was granted to Celgene on Jul 16, 2025. The application was originally filed on Jan 6, 2017. The patent is currently recorded with a legal status of "Granted".
EP3399980
- Filing Date
- Jan 6, 2017
- Status
- Granted
- Grant Date
- Jul 16, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents